Status:

RECRUITING

Role of Diet on the Microbiome of the Digestive System

Lead Sponsor:

M.D. Anderson Cancer Center

Conditions:

Colorectal Carcinoma

Eligibility:

All Genders

45+ years

Brief Summary

This study is to learn more about how diet affects the microbiome (bacteria and microorganisms) of the digestive system. Researchers want to learn if this, in turn, has an effect on if and how people ...

Detailed Description

PRIMARY OBJECTIVES: I. To evaluate the differences in dietary patterns among individuals reporting to be vegetarian and omnivorous. II. To compare the difference in stool microbiome pattern in the a...

Eligibility Criteria

Inclusion

  • GROUP I: Patients presenting for a screening colonoscopy
  • GROUP I: Age of 45 and above
  • GROUP I: Strict vegetarian diet, determined by using diet history questionnaire 3.0 National Institutes of Health (NIH)
  • GROUP I: Non smoker
  • GROUP I: Ability to understand and willingness to sign an informed consent form, complete web based dietary assessment and provide stool, colonic mucosa and blood samples
  • GROUP II: Patients presenting for a screening colonoscopy
  • GROUP II: Age of 45 and above
  • GROUP II: Omnivorous diet
  • GROUP II: Non smoker
  • GROUP II: Ability to understand and willingness to sign an informed consent form, complete web based dietary assessment and provide stool, colonic mucosa and blood sample

Exclusion

  • • Current smokers (nicotine abuse only)
  • Positive family history of colon cancer or colon cancer related syndromes
  • Recent use of antibiotics in 1 month
  • History of inflammatory bowel disease, and/or radiation enteritis or colitis
  • Pregnant and breastfeeding women
  • Women of child-bearing potential who have positive urine or serum pregnancy test
  • Heavy drinker (defined as more than 14 drinks per week)
  • Currently using anti-flatulence medications, probiotics and/or fiber supplements
  • Major dietary restrictions and/or following a special diet
  • Patient with positive fecal test/symptoms

Key Trial Info

Start Date :

September 29 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2026

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04666727

Start Date

September 29 2020

End Date

January 1 2026

Last Update

November 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

M D Anderson Cancer Center

Houston, Texas, United States, 77090